Advertisement

Related Videos

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Amit Sanyal, MD: A Clinician’s Perspective

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Jun
12
Today In Oncology
Can AI Provide an Early Alert for Breast Cancer Before Diagnosis
Urologic Surgeon Sworn in as AMA President
Head and Neck Cancer HPV-DeepSeek May Identify Earlier Signs of Postoperative Recurrence
FDA Approves Atezolizumab for Adjuvant Treatment of MRD-Positive MIBC
Perioperative Serplulimab in PD-L1–Positive Gastric Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo